NYESO alpha/beta into TRBC1 HDRT Source (pTR 262) Citations (1)

Originally described in: Reprogramming human T cell function and specificity with non-viral genome targeting.
Roth TL, Puig-Saus C, Yu R, Shifrut E, Carnevale J, Li PJ, Hiatt J, Saco J, Krystofinski P, Li H, Tobin V, Nguyen DN, Lee MR, Putnam AL, Ferris AL, Chen JW, Schickel JN, Pellerin L, Carmody D, Alkorta-Aranburu G, Del Gaudio D, Matsumoto H, Morell M, Mao Y, Cho M, Quadros RM, Gurumurthy CB, Smith B, Haugwitz M, Hughes SH, Weissman JS, Schumann K, Esensten JH, May AP, Ashworth A, Kupfer GM, Greeley SAW, Bacchetta R, Meffre E, Roncarolo MG, Romberg N, Herold KC, Ribas A, Leonetti MD, Marson A Nature. 2018 Jul 11. pii: 10.1038/s41586-018-0326-5. doi: 10.1038/s41586-018-0326-5. PubMed Journal

---

Articles Citing NYESO alpha/beta into TRBC1 HDRT Source (pTR 262)

Articles

iPSC-derived trimodal T cells engineered with CAR, TCR, and hnCD16 modalities can overcome antigen escape in heterogeneous tumors. Yang BH, Gutierrez A, Liao A, Shirinbak S, Gaertner B, Pribadi M, Chu HY, Tsai PF, Lin YE, Gonzalez D, Yeh WI, Chang CW, Bjordahl R, Lee T, Hosking M, Peralta E, Valamehr B. Cell Rep Med. 2025 Jul 15;6(7):102195. doi: 10.1016/j.xcrm.2025.102195. Epub 2025 Jun 19. PubMed

If you have published an article using this material, please email us at to have your article added to this page.